Skip to main content
SpringerLink
Log in

Sjogren’s Syndrome and Pulmonary Disease

  • Chapter
  • First Online:
Lung Inflammation in Health and Disease, Volume I

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1303))

Abstract

Sjogren’s syndrome is an autoimmune connective tissue disease targeting the exocrine glands and frequently affecting the respiratory system. The pulmonary disease is the most important extra-glandular manifestation as it carries most of the morbidity and mortality. Typically, it affects the small airways ranging from mild to severe respiratory symptoms. The upper airways are also commonly involved, predisposing sinusitis to occur more frequently than in the normal population. Lymphocytic interstitial pneumonia was initially thought to be the prevailing parenchymal disease; however, multiple cohorts report non-interstitial pneumonia to be the most frequent subtype of interstitial lung disease. In the review of high-resolution computed tomography scans, cystic lesions are commonly found and associate with both the small airways and parenchymal disease. Under their presence, amyloidosis or lymphomas should be considered in the differential. Overall, Sjogren’s syndrome has a higher risk for lymphoma, and in lungs this condition should be thought of, especially when the images reveal pulmonary nodularity, lymphocytic interstitial pneumonia and lymphadenopathy. Although, pulmonary artery hypertension was traditionally and exceptionally linked with Sjogren’s syndrome, together with systemic lupus erythematosus, they are now acknowledged to be the most common pulmonary vascular disease in east Asian populations, even over patients with systemic sclerosis. Although there are no controlled prospective trials to treat pulmonary disease in Sjogren’s syndrome, the mainstay treatment modality still falls on glucocorticoid therapy (systemic and inhaled), combined with immune modulators or alone. Most of the evidence sustains successful outcomes based on reported cases or case series.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fox RI. Sjogren’s syndrome. Lancet. 2005;366(9482):321–31.

    Article  PubMed  CAS  Google Scholar 

  2. Giles I, Isenberg D. Fatigue in primary Sjogren’s syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis. 2000;59(11):875–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Bardsen K, Brede C, Kvivik I, Kvaloy JT, Jonsdottir K, Tjensvoll AB, et al. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjogren’s syndrome. J Neuroinflammation. 2019;16(1):102.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Moutsopoulos HM. Sjogren’s syndrome or autoimmune epithelitis? Clin Rev Allergy Immunol. 2007;32(3):199–200.

    Article  PubMed  CAS  Google Scholar 

  5. Argyropoulou OD, Chatzis LG, Rontogianni D, Tzioufas AG. Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro/La and Scl-70 lymphocytic interstitial pneumonia. Clin Exp Rheumatol. 2019;37(Suppl 118(3)):249–51.

    PubMed  Google Scholar 

  6. Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren’s syndrome. Autoimmun Rev. 2010;9(5):A305–10.

    Article  PubMed  Google Scholar 

  7. Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol. 2014;6:247–55.

    PubMed  PubMed Central  Google Scholar 

  8. Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjögren’s syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012;26(1):105–17.

    Article  PubMed  CAS  Google Scholar 

  9. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. American College of Rheumatology/European league against rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2016;76(1):9–16.

    Article  PubMed  Google Scholar 

  10. Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL. Primary Sjogren’s syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open. 2013;3(11):e003569.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sjogren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58(1):61–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Kampolis CF, Fragkioudaki S, Mavragani CP, Zormpala A, Samakovli A, Moutsopoulos HM. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjogren’s syndrome. Clin Exp Rheumatol. 2018;36(Suppl 112(3)):94–101.

    PubMed  Google Scholar 

  13. Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aalokken TM, et al. Clinical pulmonary involvement in primary Sjogren’s syndrome: prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology (Oxford). 2013;52(1):173–9.

    Article  Google Scholar 

  14. Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB, et al. Lung involvement in patients with primary Sjogren’s syndrome: what are the predictors? Rheumatol Int. 2010;30(10):1317–24.

    Article  PubMed  Google Scholar 

  15. Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270–80.

    Article  Google Scholar 

  16. Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282–9.

    Article  PubMed  CAS  Google Scholar 

  17. Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sjogren syndrome. Clin Chest Med. 2010;31(3):489–500.

    Article  PubMed  Google Scholar 

  18. Strimlan CV, Rosenow EC, Divertie MB, Harrison EG. Pulmonary manifestations of Sjögren’s syndrome. Chest. 1976;70(03):354–61.

    Article  PubMed  CAS  Google Scholar 

  19. Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjogren’s syndrome. Ann Rheum Dis. 2000;59(9):709–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjogren’s syndrome: a cross sectional and longitudinal study. Thorax. 1991;46(3):180–3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Payet J, Belkhir R, Gottenberg JE, Berge E, Desmoulins F, Meyer O, et al. ACPA-positive primary Sjogren’s syndrome: true primary or rheumatoid arthritis-associated Sjogren’s syndrome? RMD Open. 2015;1(1):e000066.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Airo P, Cattaneo R, et al. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus. 2008;17(8):727–32.

    Article  PubMed  CAS  Google Scholar 

  23. Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, et al. Anti-RNP positivity in primary Sjogren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open. 2019;5(2):e001033.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87(4):210–9.

    Article  CAS  Google Scholar 

  25. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjogren’s syndrome. Clin Chest Med. 1998;19(4):687–99. viii

    Article  PubMed  CAS  Google Scholar 

  26. Gardiner P, Ward C, Allison A, Ashcroft T, Simpson W, Walters H, et al. Pleuropulmonary abnormalities in primary Sjogren’s syndrome. J Rheumatol. 1993;20(5):831–7.

    PubMed  CAS  Google Scholar 

  27. Aljanobi H, Sabharwal A, Krishnakumar B, Kramer JM. Is it Sjogren’s syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(4):482–95.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chang GH, Chen YC, Lin KM, Yang YH, Liu CY, Lin MH, et al. Real-world database examining the association between Sjogren’s syndrome and chronic rhinosinusitis. J Clin Med. 2019;8(2).

    Google Scholar 

  29. Doig JA, Whaley K, Dick WC, Nuki G, Williamson J, Buchanan WW. Otolaryngological aspects of Sjogren’s syndrome. Br Med J. 1971;4(5785):460–3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Stojan G, Baer AN, Danoff SK. Pulmonary manifestations of Sjogren’s syndrome. Curr Allergy Asthma Rep. 2013;13(4):354–60.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Volter F, Fain O, Mathieu E, Thomas M. Esophageal function and Sjogren’s syndrome. Dig Dis Sci. 2004;49(2):248–53.

    Article  PubMed  Google Scholar 

  32. Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sjogren’s syndrome. European respiratory review: an official journal of the European Respiratory Society. 2016;25(140):110–23.

    Article  Google Scholar 

  33. Mathieu A, Cauli A, Pala R, Satta L, Nurchis P, Loi GL, et al. Tracheo-bronchial mucociliary clearance in patients with primary and secondary Sjogren’s syndrome. Scand J Rheumatol. 1995;24(5):300–4.

    Article  PubMed  CAS  Google Scholar 

  34. Papiris SA, Saetta M, Turato G, La Corte R, Trevisani L, Mapp CE, et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren’s syndrome. Am J Respir Crit Care Med. 1997;156(2 Pt 1):637–41.

    Article  PubMed  CAS  Google Scholar 

  35. Stalenheim G, Gudbjornsson B. Anti-inflammatory drugs do not alleviate bronchial hyperreactivity in Sjogren’s syndrome. Allergy. 1997;52(4):423–7.

    Article  PubMed  CAS  Google Scholar 

  36. Ludviksdottir D, Janson C, Bjornsson E, Stalenheim G, Boman G, Hedenstrom H, et al. Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjogren’s syndrome. BHR Study Group Bronchial hyperresponsiveness Allergy. 2000;55(3):259–65.

    CAS  Google Scholar 

  37. Gudbjornsson B, Hedenstrom H, Stalenheim G, Hallgren R. Bronchial hyperresponsiveness to methacholine in patients with primary Sjogren’s syndrome. Ann Rheum Dis. 1991;50(1):36–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol. 1985;16(7):700–6.

    Article  PubMed  CAS  Google Scholar 

  39. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168(11):1277–92.

    Article  PubMed  Google Scholar 

  40. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632–8.

    Article  PubMed  Google Scholar 

  41. Teruuchi S, Bando M, Hironaka M, Ohno S, Sugiyama Y. Sjogren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2000;38(12):918–22.

    PubMed  CAS  Google Scholar 

  42. Lopez Velazquez M, Highland KB. Pulmonary manifestations of systemic lupus erythematosus and Sjogren’s syndrome. Curr Opin Rheumatol. 2018;30(5):449–64.

    Article  PubMed  Google Scholar 

  43. Soto-Cardenas MJ, Perez-De-Lis M, Bove A, Navarro C, Brito-Zeron P, Diaz-Lagares C, et al. Bronchiectasis in primary Sjogren’s syndrome: prevalence and clinical significance. Clin Exp Rheumatol. 2010;28(5):647–53.

    PubMed  Google Scholar 

  44. Shen TC, Wu BR, Chen HJ, Lin CL, Wei CC, Chen CH, et al. Risk of chronic obstructive pulmonary disease in female adults with primary Sjogren syndrome: a Nationwide population-based cohort study. Medicine (Baltimore). 2016;95(10):e3066.

    Article  Google Scholar 

  45. Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med. 2009;103(6):846–53.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, et al. Prognostic factors for primary Sjogren’s syndrome-associated interstitial lung diseases. Respir Med. 2019;159:105811.

    Article  PubMed  Google Scholar 

  47. Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren’s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981–8.

    Article  PubMed  Google Scholar 

  48. Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Levesque H, et al. Interstitial lung disease in primary Sjogren’s syndrome. Autoimmun Rev. 2017;16(1):48–54.

    Article  PubMed  CAS  Google Scholar 

  49. Manfredi A, Sebastiani M, Cerri S, Cassone G, Bellini P, Casa GD, et al. Prevalence and characterization of non-sicca onset primary Sjogren syndrome with interstitial lung involvement. Clin Rheumatol. 2017;36(6):1261–8.

    Article  PubMed  Google Scholar 

  50. Ramos-Casals M, Brito-Zeron P, Seror R, Bootsma H, Bowman SJ, Dorner T, et al. Characterization of systemic disease in primary Sjogren’s syndrome: EULAR-SS task force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford). 2015;54(12):2230–8.

    Article  Google Scholar 

  51. Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J. Characteristics of patients with primary Sjogren’s syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol. 2020;39(5):1561–8.

    Article  PubMed  Google Scholar 

  52. Reina D, Roig Vilaseca D, Torrente-Segarra V, Cerda D, Castellvi I, Diaz Torne C, et al. Sjogren’s syndrome-associated interstitial lung disease: a multicenter study. Reumatologia clinica. 2016;12(4):201–5.

    Article  PubMed  Google Scholar 

  53. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjogren syndrome. Chest. 2006;130(5):1489–95.

    Article  PubMed  Google Scholar 

  54. Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232(2):560–7.

    Article  PubMed  Google Scholar 

  55. Elicker B, Pereira CA, Webb R, Leslie KO. High-resolution computed tomography patterns of diffuse interstitial lung disease with clinical and pathological correlation. Journal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2008;34(9):715–44.

    Article  Google Scholar 

  56. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136–47.

    Article  PubMed  CAS  Google Scholar 

  57. Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X. Primary Sjogren syndrome. Praxis. 2012;101(24):1565–71.

    Article  PubMed  Google Scholar 

  58. Manoussakis MN, Moutsopoulos HM. Sjogren’s syndrome: current concepts. Adv Intern Med. 2001;47:191–217.

    PubMed  CAS  Google Scholar 

  59. Willeke P, Schluter B, Becker H, Schotte H, Domschke W, Gaubitz M. Mycophenolate sodium treatment in patients with primary Sjogren syndrome: a pilot trial. Arthritis Res Ther. 2007;9(6):R115.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, et al. Efficacy of rituximab in systemic manifestations of primary Sjogren’s syndrome: results in 78 patients of the AutoImmune and rituximab registry. Ann Rheum Dis. 2013;72(6):1026–31.

    Article  PubMed  CAS  Google Scholar 

  61. Vivero M, Padera RF. Histopathology of lung disease in the connective tissue diseases. Rheum Dis Clin N Am. 2015;41(2):197–211.

    Article  Google Scholar 

  62. Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, et al. Prognostic factors in interstitial lung disease associated with primary Sjogren’s syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS One. 2013;8(9):e73774.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Panchabhai TS, Farver C, Highland KB. Lymphocytic interstitial pneumonia. Clin Chest Med. 2016;37(3):463–74.

    Article  PubMed  Google Scholar 

  64. Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest. 2002;122(6):2150–64.

    Article  PubMed  Google Scholar 

  65. Strimlan CV, Rosenow EC 3rd, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med. 1978;88(5):616–21.

    Article  PubMed  CAS  Google Scholar 

  66. Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X, Tzioufas AG. Topical and systemic medications for the treatment of primary Sjogren’s syndrome. Nat Rev Rheumatol. 2012;8(7):399–411.

    Article  PubMed  CAS  Google Scholar 

  67. Justet A, Ottaviani S, Dieude P, Taille C. Tocilizumab for refractory organising pneumonia associated with Sjogren’s disease. BMJ case reports. 2015;2015

    Google Scholar 

  68. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337–44.

    Article  PubMed  Google Scholar 

  69. Brito-Zeron P, Kostov B, Fraile G, Caravia-Duran D, Maure B, Rascon FJ, et al. Characterization and risk estimate of cancer in patients with primary Sjogren syndrome. J Hematol Oncol. 2017;10(1):90.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Papageorgiou A, Voulgarelis M, Tzioufas AG. Clinical picture, outcome and predictive factors of lymphoma in Sjogren syndrome. Autoimmun Rev. 2015;14(7):641–9.

    Article  PubMed  Google Scholar 

  71. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjogren’s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev. 2005;4(1):8–15.

    Article  PubMed  Google Scholar 

  72. Bienenstock J, Johnston N, Perey DY. Bronchial lymphoid tissue. I. Morphologic characteristics. Laboratory investigation; a journal of technical methods and pathology. 1973;28(6):686–92.

    PubMed  CAS  Google Scholar 

  73. Noaiseh G, Baer AN. Toward better outcomes in Sjogren’s syndrome: the promise of a stratified medicine approach. Best Pract Res Clin Rheumatol. 2020;101475

    Google Scholar 

  74. De Vita S, Gandolfo S, Zandonella Callegher S, Zabotti A, Quartuccio L. The evaluation of disease activity in Sjogren’s syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study. Clin Exp Rheumatol. 2018;36(Suppl 112(3)):150–6.

    PubMed  Google Scholar 

  75. Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjogren’s syndrome. Mayo Clin Proc. 1989;64(8):920–31.

    Article  PubMed  CAS  Google Scholar 

  76. Graham BB, Mathisen DJ, Mark EJ, Takvorian RW. Primary pulmonary lymphoma. Ann Thorac Surg. 2005;80(4):1248–53.

    Article  PubMed  Google Scholar 

  77. Yachoui R, Leon C, Sitwala K, Kreidy M. Pulmonary MALT lymphoma in patients with Sjogren’s syndrome. Clin Med Res. 2017;15(1–2):6–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Papiris SA, Kalomenidis I, Malagari K, Kapotsis GE, Harhalakis N, Manali ED, et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjogren’s syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med. 2007;101(1):84–92.

    Article  PubMed  Google Scholar 

  79. Kurtin PJ, Myers JL, Adlakha H, Strickler JG, Lohse C, Pankratz VS, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol. 2001;25(8):997–1008.

    Article  PubMed  CAS  Google Scholar 

  80. Hernandez-Molina G, Faz-Munoz D, Astudillo-Angel M, Iturralde-Chavez A, Reyes E. Coexistence of amyloidosis and primary Sjogren’s syndrome: an overview. Curr Rheumatol Rev. 2018;14(3):231–8.

    Article  PubMed  Google Scholar 

  81. Inaty H, Folch E, Stephen C, Majid A. Tracheobronchial amyloidosis in a patient with Sjogren syndrome. Journal of bronchology & interventional pulmonology. 2013;20(3):261–5.

    Article  Google Scholar 

  82. Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, et al. Sjogren’s syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58(7):1992–9.

    Article  PubMed  Google Scholar 

  83. Sakai K, Ohtsuki Y, Hirasawa Y, Hashimoto A, Nakamura K. Sjogren’s syndrome with solitary nodular pulmonary amyloidosis. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2004;42(4):330–5.

    PubMed  Google Scholar 

  84. Perlat A, Decaux O, Gervais R, Rioux N, Grosbois B. Systemic light chain amyloidosis and Sjogren syndrome: an uncommon association. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 2009;16(3):181–2.

    Article  Google Scholar 

  85. Saraya T, Nunokawa H, Fujiwara M, Ohkuma K, Tsujimoto N, Tsukahara Y, et al. Tracheobronchial amyloidosis in a patient with Sjogren’s syndrome. Intern Med. 2016;55(8):981–4.

    Article  PubMed  CAS  Google Scholar 

  86. Gomez Correa GA, Osorno Serna J, Caceres Acosta MF, Caceres Gonzalez JD, Calle Ramirez JA, Sandoval Mesa JP, et al. Nodular pulmonary amyloidosis: a manifestation of Sjogren’s syndrome. Case reports in pulmonology. 2018;2018:9745935.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Yan S, Li M, Wang H, Yang X, Zhao J, Wang Q, et al. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjogren’s syndrome. Int J Rheum Dis. 2018;21(5):1068–75.

    Article  PubMed  Google Scholar 

  88. Fox RI. The incidence of pulmonary hypertension is higher in systemic lupus and Sjogren’s patients than in scleroderma patients in China. Lupus. 2018;27(7):1051–2.

    Article  PubMed  CAS  Google Scholar 

  89. Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW, Wang H, et al. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007;132(2):373–9.

    Article  PubMed  Google Scholar 

  90. Sato T, Hatano M, Iwasaki Y, Maki H, Saito A, Minatsuki S, et al. Prevalence of primary Sjogren’s syndrome in patients undergoing evaluation for pulmonary arterial hypertension. PLoS One. 2018;13(5):e0197297.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Mira-Avendano IC, Abril A. Pulmonary manifestations of Sjogren syndrome, systemic lupus erythematosus, and mixed connective tissue disease. Rheum Dis Clin N Am. 2015;41(2):263–77.

    Article  Google Scholar 

  92. Zhao Y, Wang H, Chen M, Zhang N, Yang ZW, Li D, et al. Primary Sjogren’s syndrome associated pulmonary arterial hypertension: 20 new cases. Zhonghua Yi Xue Za Zhi. 2019;99(37):2921–5.

    PubMed  CAS  Google Scholar 

  93. Liu Z, Yang X, Tian Z, Qian J, Wang Q, Zhao J, et al. The prognosis of pulmonary arterial hypertension associated with primary Sjogren’s syndrome: a cohort study. Lupus. 2018;27(7):1072–80.

    Article  PubMed  CAS  Google Scholar 

  94. Copple SS, Sawitzke AD, Wilson AM, Tebo AE, Hill HR. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol. 2011;135(5):678–84.

    Article  PubMed  CAS  Google Scholar 

  95. Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86(5):299–315.

    Article  Google Scholar 

  96. Corominas H, Ortiz-Santamaria V, Castellvi I, Moreno M, Morla R, Clavaguera T, et al. Nailfold capillaroscopic findings in primary Sjogren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatol Int. 2016;36(3):365–9.

    Article  PubMed  CAS  Google Scholar 

  97. Fischer A, Swigris JJ, du Bois RM, Groshong SD, Cool CD, Sahin H, et al. Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest. 2009;136(4):1072–8.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Martire MV, Santiago ML, Cazenave T, Gutierrez M. Latest advances in ultrasound assessment of salivary glands in Sjogren syndrome. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2018;24(4):218–23.

    Article  Google Scholar 

  99. Jousse-Joulin S, D’Agostino MA, Nicolas C, Naredo E, Ohrndorf S, Backhaus M, et al. Video clip assessment of a salivary gland ultrasound scoring system in Sjogren’s syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise. Ann Rheum Dis. 2019;78(7):967–73.

    Article  PubMed  Google Scholar 

  100. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ, et al. Antiphospholipid antibodies in primary Sjogren’s syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol. 1997;15(4):361–5.

    PubMed  CAS  Google Scholar 

  101. Pasoto SG, Chakkour HP, Natalino RR, Viana VS, Bueno C, Lianza AC, et al. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjogren’s syndrome. Clin Rheumatol. 2012;31(9):1331–8.

    Article  PubMed  Google Scholar 

  102. Asherson RA, Cervera R. Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol. 2007;32(2):153–8.

    Article  PubMed  Google Scholar 

  103. Biyajima S, Osada T, Daidoji H, Hisaoka T, Sakakibara Y, Tajima J, et al. Pulmonary hypertension and antiphospholipid antibody in a patient with Sjogren’s syndrome. Intern Med. 1994;33(12):768–72.

    Article  PubMed  CAS  Google Scholar 

  104. Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren’s syndrome among 1,726 registry participants. Arthritis Rheum. 2011;63(7):2021–30.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s syndrome international registry. Am J Ophthalmol. 2010;149(3):405–15.

    Article  PubMed  Google Scholar 

  106. van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol. 1969;82(1):10–4.

    Article  PubMed  Google Scholar 

  107. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, Albany Medical College, Albany, NY, USA

    Ruben A. Peredo

  2. Division of Pulmonary & Critical Care Medicine, Albany Medical College, Albany, NY, USA

    Scott Beegle

Authors
  1. Ruben A. Peredo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Beegle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ruben A. Peredo .

Editor information

Editors and Affiliations

  1. Department of Molecular & Cellular Physiology, Albany Medical College, Albany, NY, USA

    Yong-Xiao Wang

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Peredo, R.A., Beegle, S. (2021). Sjogren’s Syndrome and Pulmonary Disease. In: Wang, YX. (eds) Lung Inflammation in Health and Disease, Volume I. Advances in Experimental Medicine and Biology, vol 1303. Springer, Cham. https://doi.org/10.1007/978-3-030-63046-1_12

Download citation

Publish with us

Policies and ethics

Search

Navigation